Pre-exposure prophylaxis (PrEP) employs antiretroviral agents in HIV-negative individuals to avert viral acquisition. Initial efficacy trials of daily oral regimens combining emtricitabine and ...

Pre-exposure prophylaxis (PrEP) has emerged as a transformative biomedical intervention to prevent HIV infection among people at substantial risk. Its adoption reflects a complex interplay of clinical ...

In a far-reaching effort to understand the factors contributing to HIV transmission among sexual and gender minority (SGM) individuals and improve HIV prevention strategies, a team of scientists at ...

For several years, pre-exposure prophylaxis against HIV (PrEP) has been a major success in preventing new cases. However, individuals on PrEP typically engage in riskier sexual behavior and thus are ...

社区监管下使用药物的人群面临较高的HIV感染风险。该随机对照试验采用混合方法学（mixed-methods approach）考察社区监管下使用药物的男性及其女性伴侣对暴露前预防用药（pre-exposure prophylaxis, PrEP）的接受情况。研 社区监管下使用药物的人群面临较高的HIV感染风险。该随机对照试验采用混合方法学（mixed-methods approach）考察社区监管 ...

NCCN now recommends pemivibart pre-exposure prophylaxis for patients with B-cell lymphomas and other profoundly ...

The EUA was supported by primary data from the phase 3 PROVENT trial. The Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for Evusheld (tixagevimab co-packaged with ...

HIV-1 infection remains a major public health problem, with an estimated 38.4 million people living with HIV and 1.5 million new HIV infections reported worldwide in 2021. The risk of HIV infection ...

Witkoppen patients are asking if long acting HIV prevention could mean more privacy, less stigma, and one less thing to ...

Background Understanding the ‘real-world’ challenges of delivery of pre-exposure prophylaxis (PrEP) among men who have sex ...

What is Pre-Exposure Prophylaxis (PrEP)? Pre-Exposure Prophylaxis (PrEP) is an HIV prevention strategy that enables HIV-negative people to stay HIV-negative by taking anti-HIV drugs (also called ...